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Background: Although over-the-counter traditional Chinese herbal medicine (COTC) is commonly used to treat
everyday illness in many parts of the world, no population-based study has been done to examine the prevalence
and factors associated with COTC-related adverse events.
Methods: A cross-sectional telephone survey was conducted among Hong Kong Chinese adults in 2011 (n = 1100)
with informed verbal consent. Stepwise logistic regression of demographic, attitudinal and behavioral variables was
used to determine factors associated with past-year adverse events.
Results: Of study respondents, 71.7% (789/1100) reported past-year COTC use and 2.3% (25/1100) reported at least
one COTC-related adverse event in the past year. Of the 27 adverse events cases reported among COTC users, the
most common were allergic reactions (n = 11) dizziness (n = 5), and gastro-intestinal problems (n = 4). Pills/capsules
were the dosage form that caused the highest proportion of adverse events (n = 10), followed by plasters (n = 7),
creams/ointments (n = 5), and ingestible powders (n = 2).
Although COTC users reporting adverse events were more likely to report greater practices to avoid adverse events
(OR = 6.47; 95% CI: 1.38-30.3); they were also more likely to possess lower education levels (OR = 9.64, 95% CI: 2.20-42.3)
and to have received COTC information from non-reliable, mass-media information sources such as magazines
(OR = 3.32; 95% CI: 1.01-8.50) or television (OR = 2.93; 95% CI: 1.03-10.7). Package labels were also felt to be unclear by
42.9% of COTC users. A large proportion of COTC users demonstrated low levels of COTC-related knowledge, while
the main impediment to greater information-seeking was the belief that reliable COTC information is not obtainable
from Western health professionals.
Conclusions: Despite global movements toward more stringent complementary medicine regulation, the limited
accessibility of reliable information and widespread misperceptions among consumers present major challenges for the
safe use of complementary medicine.
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The use of complementary and alternative medicine has
been increasing worldwide in recent decades. One reason
for its continued popularity is the pervasive belief that it is
a safer alternative to conventional allopathic medicine [1].
In response to increasing popularity of complementary
medicine, the World Health Organization has outlined a
framework of action for greater integration of traditional
medicine/complementary and alternative medicine into
national health care systems [2]. Components of this
World Health Organization Traditional Medicine Strategy
included the regulation of herbal medicines and the pro-
motion of rational traditional medicine use by consumers.
In East Asian cultures, Traditional Chinese Medicine
(TCM), as a form of complementary medicine, has long
been commonplace for treating a spectrum of illnesses [3].
In recent years, TCM products have become more readily
available in non-Asian countries [4-9]. By 2002, TCM ex-
ports from China were reported to be as high as 100 mil-
lion USD per year [10,11].
Although TCM has a long tradition of use in Hong
Kong, its regulation commenced only after the 1997
handover [12,13]. Hong Kong’s regulatory bodies have
since classified Chinese herbal medicines into two gen-
eral types of products [14]. The first type are processed
medicinal materials for decoctions (Yin Pian) that are
sold by licensed retailers [15]. These products are used
for customized formulations based upon prescriptions
from TCM doctors. The second type of TCM products
are proprietary over-the-counter Chinese medicines
(COTC) that do not require management by licensed
purveyors. Similar to Western over-the-counter drugs,
COTC are mass-manufactured and sold in finished dose
form (such as pre-packaged pills or ointments).
Formal registration of TCM phytotherapeutic products
in Hong Kong commenced in 1999. The Chinese Medi-
cine Ordinance of 2003 mandated that all COTC products
submit laboratory certification for formal registration and
that all labels include information on dosage, active ingre-
dients, indications, and contra-indications for use [16]. All
COTC products must undergo full formal registration or
be under a transitional licensure scheme in order to be
sold legally in Hong Kong [17]. Of the 10,518 COTC
products available in Hong Kong as of January 2012, only
188 (1.8%) have completed full formal registration [18],
while the remaining products remain under the transi-
tional scheme.
It is worthwhile to document adverse events in a
population that is in the process of implementing formal
COTC registration, in order to assess the effectiveness
of these regulations and to document patterns of adverse
events. Despite efforts to regulate TCM products in
Hong Kong, reports of TCM poisoning cases have in-
creased [19,20]. Studies conducted in the US and Asiahave noted that many TCM drugs were compromised by
adulteration with western pharmaceuticals such as silden-
afil, with heavy metal contamination, with inadequate la-
beling, and with commercial counterfeiting [19-28]. In
Hong Kong, as in other countries in the East Asia region,
self-medication using over-the-counter TCM without con-
sultation of TCM professionals is a widespread cultural
practice for conditions ranging from the common cold to
chronic health conditions [29,30]. Studies conducted in
the past decade have reported that about one in seven
TCM-related toxicity cases in Hong Kong were attributed
to COTC use [19,20]. Past studies in Hong Kong, however,
have been conducted on small non-representative samples
[31] or from emergency room admissions [19,20,32].
These studies may present a highly biased picture of the
COTC-related harms in the general population, since only
severe adverse events are likely to be treated in emergency
rooms. Internationally, studies on complementary medi-
cine have noted relatively low levels of adverse drug reac-
tions as compared to conventional Western drugs [33-35].
However, these studies of adverse events were typically
conducted on patients who were prescribed complemen-
tary and alternative medicine by licensed practitioners and
not self-medicating. Studies conducted in numerous
countries have shown that self-medication, a noted risk
factor for adverse events, is a common practice for
allopathic as well as complementary medicine [36-40]
but data on the prevalence of adverse events among
self-medicating users of complementary medicine is
limited [41].
In order to address the above knowledge gaps, this
study examines the occurrence of COTC-related adverse
events and factors that may predispose individuals for
COTC adverse events in a population-based sample of
Chinese adults. In Hong Kong, the difference between
over-the-counter COTC and herbal TCM is well-known,
since herbal TCM requires a prescription by a TCM
doctor and customized preparation of the medicine,
whereas COTC is sold in mass-manufactured, pre-dosed
forms that do not require prescriptions. The study re-
sults can inform consumer regional COTC drug safety
guidelines and offer insights for other governments that
are in the process of strengthening COTC regulation.
Methods
The study population
The target population was comprised of all Cantonese-
speaking Hong Kong residents over the age of 18. After
the preliminary survey instrument was anonymously
pilot-tested on 50 respondents and revised for clarity and
accuracy, an anonymous, random telephone survey was
conducted in September 2011 using the ‘last birthday’
method of selecting respondents. For unanswered calls,
at least 4 other independent calls were made. Trained
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quial Cantonese. The sample size was derived from power
calculations to allow for adequate sample size to conduct
multivariable logistic regression with ten covariates. After
briefing the individual about the purpose of the survey, in-
terviewers obtained verbal consent to participate in the
study before conducting the interview. Research ethics ap-
proval was obtained from the ethics board of the sponsor-
ing university. A flow chart of the study recruitment
process is shown below (Figure 1). Of households with an
eligible member, the overall response rate was 70.1%.
Measurements
Socio-demographic and background information
The socio-demographic and background information of re-
spondents were recorded (see Table 1). Respondents were
then asked whether they had used COTC products in the
preceding 12 months. Respondents were asked about their
knowledge about COTC safety, potential harms, side ef-
fects, and possible drug interactions between COTC with
TCM or conventional Western drugs (see Table 1). Correct
responses to these six items were summed to derive a sum-













Figure 1 Study recruitment.COTC-related perceptions and preventive practices
Respondents were also asked about their perceptions
about the benefits of COTC use, the severity and suscep-
tibility to COTC-related adverse events, and barriers to
safe use of COTC. Respondents who had used COTC in
the past year were also asked seven items about their
COTC-related practices (see Table 2). Summative scores
were calculated for each of these domains by summing
the responses (Agree = 2, Not sure = 1, Disagree = 0) to
each of the constituent items. For all summative scales,
higher scores reflected greater levels of that domain
(Table 3).
Proprietary Chinese medicine use patterns and reported
adverse events among users
Respondents who had used COTC in the past year were
asked about the health condition for which the COTC
product was used (see Table 3 for response categories).
The list of conditions for which COTC products may
have been used was compiled by licensed TCM practi-
tioners and checked by research assistants against TCM
products sold over-the-counter in local drug stores. In
the pilot test, no other categories of COTC drugs wereo pick-up of working phone line
lity for study unknown)
valid phone numbers:
non-household lines (e.g. businesses) 
phone numbers not in use
fax machines, 
out-of service lines 
one line picked up but no eligible
ents at home despite repeated calls
used to participate
mplete interviews
Table 1 Characteristics of the study respondents
COTC users Non-users
P (χ2)
Total sample Hong Kong
population(n = 789) % (n = 311) % (n = 1100) % (95% CI)
Gender 0.284
Male 46.3% 49.8% 47.3% (44.3-50.2) 46.6%a
Female 53.7% 50.2% 52.7% (49.9-55.7) 53.4%
Age group 0.782
18 – 24 y 10.0% 9.0% 9.7% (8.0-11.5) 10.2%a
25 – 34 y 18.4% 21.5% 19.3% (16.9-21.6) 18.2%
35 – 44 y 19.5% 18.0% 19.1% (16.8-21.4) 19.0%
45 – 54 y 22.1% 20.3% 21.5% (19.1-24.0) 21.6%
55 – 64 y 15.3% 14.8% 15.2% (13.1-17.3) 15.4%
65 y or above 14.7% 16.4% 15.2% (13.9-17.3) 15.6%
Education 0.627
No formal schooling/Primary 15.9% 16.8% 16.2% (13.9-18.3) 25.4%b
Secondary 1 - 7 55.5% 57.6% 56.1% (52.8-58.7) 51.5%
At least some post-secondary 28.6% 25.7% 27.6% (24.9-30.2) 22.9%
Household income (1 USD = 7.8 HKD) < 0.001
< 15000 HKD/month 22.5% 31.6% 25.1% (22.3-27.8) 43.1%b
15000 – 29999 HKD/month 46.2% 33.8% 42.8% (39.7-45.9) 30.0%
> 30000 HKD/month 31.2% 34.6% 32.2% (29.2-35.1) 26.9%
Employment status 0.402
Employed at least part-time 51.2% 50.0% 50.9% (47.9-53.8) 52.1%c
Homemaker 25.0% 22.6% 24.3% (21.8-26.8) 18.5%
Other (student, unemployed, retired) 23.8% 27.4% 24.9% (29.2-35.1) 29.0%
Health insurance
Have health insurance 52.3% 48.5% 0.263 51.2% (48.2-54.1) NA
Self-perceived health status <0.001
Very good/Good 49.1% 55.2% 50.8% (47.8-53.7) NA
About average 46.8% 38.5% 44.5% (41.5-47.4)
Bad/Very bad 4.0% 6.5% 4.8% (3.5-6.0)
COTC-related adverse event history
Reported past year adverse event 3.2% NA 2.3% (1.3-3.1) NA
Correct response to COTC knowledge items
(correct answer in parentheses)
Cannot cause long term bodily damage (No) 24.0% 19.0% 0.09 22.7% (20.2-25.2) NA
Can negatively interact w/western drugs (Yes) 80.5% 77.5% 0.224 79.5% (77.1-81.9) NA
Can have interactions with herbal TCM (Yes) 51.6% 41.8% 0.003 48.9% (45.9-51.8) NA
COTC may have side effects (Yes) 73.9% 66.9% 0.984 71.9% (69.2-74.5) NA
Used only for acute illness (e.g. flu) (No) 45.3% 47.9% 0.443 47.2% (44.2-50.1) NA
Overdose is possible (Yes) 53.3% 53.2% 0.982 53.3% (50.3-56.2) NA
a2011 Hong Kong Census provisional figures; b2006 Hong Kong Population By-Census; c2004 Hong Kong Population Health Survey; NA = Not available.
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labels had clear instructions and whether they experi-
enced any acute COTC-related adverse event within
2 days of use. Respondents were read a list of common
adverse events that was initially compiled by two TCMpractitioners with extensive clinical experience. In the
pilot-testing of the instrument, respondents were
asked about adverse events with extensive probing by
the interviewers. Since no other adverse events were
noted in the pilot study, it was concluded that all
Table 2 COTC-related perceptions and preventive practices among users (n=789)
Response choices
Agree Not sure Disagree
Perceived benefits
At least as effective as western drugs 31.9% 22.8% 45.2%
Less side effects than western drug 69.1% 15.7% 15.2%
Cheaper than western drug 37.4% 18.8% 43.9%
Help reduce medical costs 42.1% 17.9% 39.9%
Safer than western drugs 39.4% 21.3% 39.3%
Helps people to stay healthy 54.9% 21.4% 23.6%
Perceived severity
COTC poisoning is more serious than for western drugs* 34.2% 42.7% 22.9%
COTC poisoning due to drug interaction could be fatal 82.8% 12.0% 5.2%
COTC overdose could result in hospitalization 87.5% 7.7% 4.8%
Perceived susceptibility
Easy to misuse COTC due to unclear instruction 33.8% 5.9% 60.4%
I am likely to experience COTC-related side effects 9.9% 8.4% 81.7%
I am likely to experience drug interactions with COTC 37.6% 24.8% 37.6%
Government has adequate regulation for COTC safety* 15.0% 20.6% 64.5%
Perceived barriers
Making TCM doctor appointments for COTC advice is inconvenient 27.2% 31.7% 41.1%
TCM prescriptions are expensive 36.9% 25.5% 37.6%
Easy to find COTC information on the internet 16.2% 62.4% 21.4%
Physicians do not have reliable knowledge about COTC 71.8% 16.9% 11.3%
Pharmacists do not have reliable COTC knowledge 65.3% 17.8% 16.9%
COTC package instructions are inadequate or unclear 42.9% 18.1% 39.0%
Preventive practices** Habitually Occasionally Never
Read COTC labels 66.8% 24.0% 9.3%
Read COTC package inserts 55.9% 32.0% 12.2%
Ask COTC information from retailers 13.2% 35.7% 51.1%
Search online for COTC information 3.9% 15.6% 80.5%
Ask Western MDs or pharmacists about COTC use 3.3% 12.6% 84.2%
Tell their medical doctor about TCM use 33.2% 20.6% 46.2%
Asked TCM practitioner about COTC 8.1% 22.0% 69.9%
*Item not included in summative scale score due to low item-total correlation.
**Original 5-point Likert responses were recoded as: Habitually (Always or Often), Occasionally (Sometimes or Seldom) and Never due to small cell counts.
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ment. The final survey instrument included an “other”
response category for later respondents to report
adverse events that may have been missed. Respon-
dents who experienced adverse reactions were further
asked about the dosage form of the COTC product,
the condition for which the COTC product was used,
and where they sought help for the adverse event (self-
treatment, Western MD, TCM practitioner or other
health professional). COTC users were also asked where
they typically obtained information about COTC use
(See Table 3).Statistical analysis
Descriptive statistics such as percentages and their re-
spective 95% confidence intervals were reported for the
prevalence data. Unadjusted analysis performed using
chi-square, and t-tests were used to examine the associ-
ations between predictor variables the adverse event
outcome variable. Summative scores were created for
knowledge, TCM-related perceptions, and adverse event
preventive behaviors domains by summing the responses
in these domains. Items were removed from the scales
to maximize the reliability coefficients (the final reliability
coefficients ranged from 0.52 to 0.68). The scales were
Table 3 Comparison of COTC users (n = 789) who reported adverse events compared with those who did not report
adverse events (AE)
Reported adverse
events (n = 25)
No adverse





Conditions for past year COTC use % (95% CI) % (95% CI) % (95% CI)
Cold/Flu 64.0% (43.8-84.2) 53.7% (50.1-57.2) 0.308 54.0% (50.5-57.5)
GI/Digestive problems 44.0% (23.1-64.9) 44.0% (40.8-47.9) 0.971 44.0% (40.3-47.2)
Musculoskeletal pains 76.0% (58.0-94.0) 42.7% (39.2-46.2) 0.001 43.9% (40.3-47.2)
“Qi” (氣) imbalancesa 32.0% (12.3-51.7) 23.4% (20.4-26.4) 0.321 23.7% (20.7-26.7)
General health enhancement 20.0% (3.1-36.9) 13.5% (11.1-15.9) 0.351 13.7% (11.3-16.1)
Sleep problems 20.0% (3.1-36.9) 4.8% (3.3-6.4) 0.001 5.3% (3.8-6.9)
Skin and hair problems 8.0% (0.0-19.4) 4.1% (2.7-5.5) 0.333 4.3% (2.8-5.6)
Treating open wounds 8.0% (0.0-19.4) 3.8% (2.4-5.2) 0.287 4.1% (2.6-5.3)
Chronic respiratory problems 0.0% (0.0-0.0) 3.5% (2.2-4.8) 0.339 3.5% (2.2-4.7)
Slimming/Weight loss 8.0% (0.0-19.4) 0.9% (0.2-1.6) 0.001 1.1% (0.4-1.9)
Blood Pressure/heart conditions 4.0% (0.0-12.3) 0.4% (0.0-0.8) 0.012 0.5% (0.0-1.0)
Improving mental functioning/memory 8.0% (0.0-19.4) 0.0% (0.0-0.0) <0.001 0.3% (0.0-0.6)
Sexual health/reproductive conditions 0.0% (0.0-0.0) 0.4% (0.0-0.8) 0.754 0.4% (0.0-0.8)
Vision problems 0.0% (0.0-0.0) 0.3% (0.0-0.6) 0.798 0.3% (0.0-0.6)
All other conditionsb 4.0% (0.0-12.3) 1.7% (0.8-2.6) 0.392 1.8% (0.9-2.7)
Usual source(s) of COTC information
TV 24.0% (6.0-42.0) 7.6% (5.7-9.5) 0.003 8.1%
Retailers 40.0% (19.4-60.6) 22.2% (19.0-24.0) 0.037 22.8%
Internet 4.0% (0.0-12.3) 5.7% (4.0-7.3) 0.724 5.6%
Newspapers 16.0% (0.6-31.4) 7.4% (5.5-9.2) 0.109 7.6%
Health professionals 8.0% (0.0-19.4) 11.6% (9.4-13.9) 0.570 11.6%
Friends and Family 52.0% (31.0-73.0) 42.9% (39.4-46.4) 0.377 43.4%
Magazines 20.0% (3.1-36.9) 4.9% (3.3-6.4) 0.001 5.3%
Drug labels/inserts 66.7% (39.4-90.0) 56.4% (51.2-58.8) 0.387 56.7%
Other sources (Books) 16.0% (6.0-31.4) 7.1% (5.2-8.9) 0.092 7.6%
Mean (SD) Mean (SD) Mean (SD)
Practice score [out of-28] 12.2 (5.8) 9.12 (5.0) 0.002 9.22 (5.00)
COTC Knowledge scores [max = 6) 3.64 1.60) 3.52 (1.45) 0.712 3.52 (1.45)
Perceived benefits score [max = 12] 6.76 (3.40) 6.67 (3.01) 0.851 6.67 (2.99)
Perceived COTC AE severity [max = 4] 3.32 (1.14) 3.61 (0.87) 0.219 3.60 (0.88)
Perceived AE susceptibility [max = 6] 2.00 (1.99) 2.01 (1.71) 0.902 2.01 (1.72)
Perceived COTC info barriers [max = 12] 7.36 (2.31) 7.24 (2.20) 0.801 7.23 2.21)
*χ2 or t-test p-value.
aQi (氣) imbalances refer to TCM concept of bodily vital energy disharmonies [38].
bOther conditions include: Headache, ear ache and multi-symptom conditions.
Kim et al. BMC Complementary and Alternative Medicine 2013, 13:336 Page 6 of 12
http://www.biomedcentral.com/1472-6882/13/336examined in the multivariable models after collapsing the
scores into 3 levels: high score (score > interquartile range),
mid-range score (within interquartile range) and low score
(score < interquartile range).
Stepwise logistic regression was conducted to determine
the factors associated with whether the respondent had
experienced a past-year adverse event. For multivariablemodels, those socio-demographic variables which had p <
0.15 in the unadjusted analyses, and were first used
as candidate variables for stepwise multivariable logis-
tic regression models of socio-demographic factors
only. A second multivariable logistic regression model
(full model) was then conducted by also including
attitudinal and behavioral variables as candidate









% (95% CI) OR (95% CI) OR (95% CI)
Total sample of COTC users 3.2% (1.9-4.4) –
Gender 0.146
Male 2.2% (0.7-3.7) 1.00 –
Female 4.0% (2.1-5.9) 1.40 (0.56-3.50)
Age 0.043
18-44 1.9% (0.5-3.2) 1.00 –
45+ 4.4% (2.4-6.4) 1.30 (0.49-3.49)
Educational level 0.002
F6 and higher 0.7% (0.0-1.6) 1.00 1.00
Up to F5 (grade 11) 4.8% (2.8-6.7) 7.43 (1.74-31.8)2 9.64 (2.20-42.3)2
Household income 0.291
HKD 15,000 or more 4.3% (1.2-7.5) – –
HKD 0–14,999 2.7% (1.4-4.1)
Health insurance 0.100
Insured 4.3% (2.2-6.3) 1.00 –
Uninsured 2.2% (0.1-3.6) 1.34 (0.57-3.16)
Employment 0.008
Employed or FT student 1.8% (0.1-3.0) 1.00 –
All else 5.1% (2.7-7.5) 1.92 (0.79-4.64)
COTC Knowledge levels 0.307
High knowledge score (> IQR) 6.0% (0.1-12.0) –
Score in interquartile range 2.9% (1.6-4.2)
Low knowledge score (< IQR) 2.9% (0.0-6.9)
Perceived benefits 0.141
High benefits score (>IQR) 2.2% (0.3-4.1)
Score in interquartile range 4.2% (2.3-6.0)
Low benefits score (< IQR) 0.9% (0.0-2.8)
Perceived barriers 0.472
Low barriers score (< IQR) 3.2% (0.4-5.9) –
Score in interquartile range 2.8% (1.3-4.2)
High barriers score (>IQR) 4.9% (1.0-8.7)
Perceived severity of COTC AE 0.260 –
High severity score (>IQR) 2.7% (1.4-4.0)
Score in interquartile range 4.3% (0.9-7.7)
Low severity score (< IQR) 7.7% (0.0-18.7)
Perceived susceptibility to COTC AE 0.604
High susceptibility Score (>IQR) 2.9% (0.4-5.4) –
Score in interquartile range 2.6% (1.1-4.2)
Low susceptibility score (< IQR) 4.1% (1.3-6.9)
Preventive practices 0.008
Low preventive practices Score (< IQR) 1.4% (0.0-3.3) 1.00
Score in interquartile range 2.5% (1.0-3.9) 2.59 (0.55-12.1)
High preventive practices score(>IQR ) 6.0% (2.7-9.4) 6.47 (1.38-30.3)1
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Table 4 Correlates of adverse events (AE) among over-the-counter Chinese medicine users (n = 789) (Continued)
Exposed to any TCM warnings 0.650
Yes, 2.9% (1.4-4.4) –
No/Can’t recall 3.5% (1.3-5.6)
Self-efficacy for obtaining reliable COTC info? 0.123
Yes, have self-efficacy 2.4% (1.0-3.8) 1.00
No/Not sure 4.4% ( 2.1-6.7) 1.42 (0.59-3.42)
Usual source of COTC info
Health professionals 2.2% (0.0-5.3) 0.570§ –
Internet 2.3% (0.0-6.9) 0.724§ –
Package labels & inserts 3.1% (1.2-4.6) 0.387§ –
Family & Friends 3.8% (1.8-5.9) 0.377§ –
Retailers 5.6% (2.2-9.0) 0.037§ 1.98 (0.78-5.09)
Newspapers 6.7% (2.0-13.2) 0.109§ 0.61 (0.11-3.26)
TV 9.4% (2.0-16.7) 0.003§ 2.93 (1.01-8.50)1
Magazines 11.9% (1.7-22.1) 0.001§ 3.32 (1.03-10.7)1
Books 6.9% (0.2-13.6) < 0.001§ 2.74 (0.84-8.90)
*Stepwise regression model using socio-demographic variables with p-value < 0.15 in the unadjusted analyses as candidate variables, non-significant covariates
are shown with OR (95% CI) prior to removal from the final model.
**Stepwise regression model using educational attainment in addition to attitudinal and behavioral variables with p-value < 0.15 in the unadjusted analyses as
candidate variables.
non-significant covariates are shown with OR (95% CI) prior to removal from the final model. Full Final model showed Hosmer-Lemeshow statistics = 0.595 and
Variance Inflation Factor = 1.19.
§p-values for comparison with those not reporting those behaviors.
– Variable not entered as candidate variable into multivariate model.
1p<0.05, 2p < 0.01.
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association with the outcome variable (p < 0.15) in un-
adjusted analyses (see Table 4). Model fit was exam-
ined using Hosmer-Lemeshow statistics. Models were
checked for collinearity between variables by using
variance inflation factor (VIF) statistics and by checking
the standard errors of the covariates. All statistical ana-
lyses were conducted using SPSS for Windows version
16.0 (SPSS Inc, Chicago, 2007).Results
The study sample was largely similar to the general
Hong Kong population of adults, except that the study
participants reported slightly higher levels of education
and income (Table 1).
Of the study sample 2.3% (25/1100) reported a COTC-
related adverse event in the past year.
The study sample showed moderate levels of COTC-
related knowledge (Table 1). Although the majority of
respondents were aware that COTC can have side effects
and can interact with Western drugs, only about half
were aware that COTC could interact with herbal TCM
concoctions or that COTC overdosing is possible. There
were no significant differences in knowledge levels be-
tween COTC users and non-users.COTC-related perceptions and preventive practices
among COTC users are shown on Table 2. Rather than
cost-related aspects or beliefs about drug efficacy, the
main stated benefits of COTC use were the fewer per-
ceived side effects than western medications. While the
vast majority of COTC users (>80%) agreed that COTC-
related adverse events could cause hospitalization and
even death, respondents demonstrated low perceptions
of personal susceptibility to adverse events. The main
barriers to greater COTC information seeking behaviors
cited by respondents were the perception that reliable
knowledge of COTC products could not be obtained
from Western medical professionals and that package
instructions on COTC products are unclear. COTC
users reported a wide range of COTC-related health
practices. While more than half would “habitually” read
labels and package inserts, only a minority would rou-
tinely seek information about COTC from retailers or
TCM practitioners, or tell their western medical doctors
about their COTC use. Greater than 80% of respondents
reported that they “never” sought information from
Western health professionals or the Internet.
A comparison of COTC users who had experienced
adverse events and those who had not is shown in
Table 3. Among all COTC users, the most common
health conditions which COTC was used for were:
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etal pains, “Qi” imbalances (a TCM concept referring to
bodily yin-yang disharmony) [42] and for enhancing
general health. Use for other health concerns was infre-
quent. COTC users reporting adverse events were
significantly more likely to have used COTC products
for musculoskeletal pains, sleep problems, weight loss,
cardiovascular conditions, and improving mental func-
tioning. Respondents reporting adverse events were also
more likely to obtain their COTC information from
television, magazines and retailers. There were no statis-
tically significant differences between the COTC users
who experienced adverse events with those who did
not with respect to perceived benefits, knowledge of
COTC harms, perceived severity, perceived susceptibil-
ity, or perceived barriers to COTC information seeking
(Table 3). When compared with their counterparts
who did not report adverse events, however, respondents
who reported adverse events had higher levels of
preventive practices. Respondents who reported adverse
events were also more likely to report mass media
sources of COTC information. Nearly all of respondents
citing “other” sources reported reading about TCM
products in books, although those individuals were not
health professionals.
Figure 2 demonstrates the description of the alleged
adverse drug events reported. Among the 27 adverse
events reported by 25 individuals in this study, the high-
est proportion of COTC reactions 37% were caused by
pills/capsules (n = 10), while 25.9% were caused by plas-
ters (n = 7), 18.5% by ointments/creams (n = 5), 11.1%
from powder forms of COTC (n = 2), and none from
syrups or tinctures. Allergic reactions, dizziness/disorien-
tation, and gastro-intestinal symptoms (such as diarrhea,
stomach ache and cramping) comprised nearly three-
quarters of all the adverse reactions reported. Only about















Figure 2 Description of adverse event dosage forms and types of advmedical treatment. Of these eight respondents, allergic
reactions accounted for 2 cases, while severe nausea, dizzi-
ness, sleep problems, stomach ache, fever, and exacerba-
tion of influenza-like symptoms each accounted for one
case (data untabulated).
The correlates of adverse events among COTC users are
shown in Table 4. The unadjusted odds ratios for adverse
events are also shown. Although factors such as older age
were associated with adverse events, the multivariate ana-
lyses limited to socio-demographic factors showed that only
those with less than grade 11 education were more likely
(OR = 7.43) to have had an adverse event. The full multi-
variate analyses that also included knowledge, attitude, and
practice variables as candidate variables, showed that those
with less than grade 11 education (OR = 9.64), those who
had greater adverse event preventive practice scores (OR =
6.3), and those who obtained COTC information from
magazines (OR = 3.32) and television (OR = 2.93) were
more likely to report COTC-related adverse events (p <
0.05). The correlates of adverse events in the entire study
sample (COTC-users and non-users) were not substan-
tively different to those reported for COTC-users only (data
not tabulated). The proportion reporting adverse events
was only 2.2% in the entire study sample (1.5% for males,
and 2.9% for females). The multivariable logistic regression
odds ratios were very similar to those shown in Table 4.
Discussion
The prevalence of COTC-related adverse events (3.2%
among COTC users) is slightly lower than the 4.6% re-
ported among patients prescribed complementary and al-
ternative medicine in a European hospital setting [34] and
the 6.5% reported in a U.S. hospital-based study of con-
ventional allopathic drugs [43] but considerably higher
than the 0.4% reported in a 5.5 year prospective study on
patients prescribed alternative medicine [32,44]. Methodo-
logical differences in study designs and study samples42.3%
19.2%
15.4%
7.7% 7.7% 7.7% 7.7%
15.4%
Types of Adverse Events
erse events.
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The results of this study, nonetheless, expose cases of
COTC-related adverse events that had not been detected
by previous clinic-based studies in Hong Kong. Since
the majority of individuals with adverse events in our
population-based study did not seek any type of profes-
sional medical treatment (and none sought emergency
care), COTC-related adverse events reported primarily by
emergency room clinicians appear to represent a small
fraction of COTC-related adverse events in Hong Kong.
Our results thereby indicate that COTC-related adverse
events are an under-appreciated public health issue that
may require greater scrutiny and improved surveillance.
Since the list of adverse drug reactions includes many
items which may be quite mild (such as minor skin irri-
tation), the clinical significance of these adverse events
is unknown and represents a limitation of the study.
Nonetheless, approximately 1% of the COTC users
(n = 8) had an adverse reaction for which they sought
medical treatment, giving a rough estimate of more se-
vere adverse events in the population. Although a pre-
vious study conducted on emergency room patients in
Hong Kong reported that rashes and systemic allergic
reactions comprised over 90% of the adverse events
[35,45], our study found that these conditions only rep-
resented about half of the adverse events in the general
population while dizziness, nausea, vomiting, and gastro-
intestinal problems comprised most of the remaining
cases. Adverse events such as sleep disturbances, ex-
acerbation of existing illnesses, and heart-related prob-
lems that were previously unreported in the COTC
literature were also shown in this study.
Despite government efforts to promote safe COTC use
through more stringent labeling requirements, over one
third of respondents still find COTC labels to be unclear.
Part of the reason for the ambiguity is that many of the
listed drug actions, such as “dispelling dampness” or “nor-
malizing the gall-bladder”, require advanced understanding
of TCM concepts. In our study, the observed preference
for unreliable sources of COTC information (e.g. mass
media magazines) was shown to be the primary behavioral
risk factor for COTC-related adverse events. Health infor-
mation presented in the mass media is often inaccurate or
incomplete [43-47]. Even among Hong Kong Chinese, a
population with a long tradition of TCM use, TCM-related
misconceptions and low risk perception of COTC harms
are pervasive. Hence, strategies promoting safe COTC use
must also include raising public awareness of alternative
medicine safety. Our study corroborated findings from
other regions that showed low risk perceptions related to
complementary and alternative medicine use [25,48].
The importance of increasing risk perception is par-
ticularly necessary since the inclination to self-manage
health problems is strongly associated with alternativemedicine use [49,50]. In our study, COTC-users self-
medicated without consulting TCM practitioners. Case
reports about the adverse effects from misuse of comple-
mentary and alternative medicine from self-treatment
abound in the medical literature [51-53]. It is particu-
larly noteworthy that a large proportion of adverse event
victims reported books as a common source of COTC
information, even though none of those individuals were
health professionals. Self-management of health using
COTC among people untrained in TCM precepts has great
potential for inappropriate COTC use, particularly since
TCM users in Hong Kong possess lower educational levels
[54]. TCM treatments rely upon holistic diagnosis of the
underlying syndrome while the prescribed treatments for a
particular symptom may vary greatly between individuals.
In addition to addressing pervasive COTC misconcep-
tions, there appears to be a need to reduce barriers to
obtaining reliable drug safety information. Past surveys of
Hong Kong pharmacists [55] and western-trained medical
doctors [56] demonstrated a low level of TCM knowledge.
Greater dialogue between TCM manufacturers, retailers,
and Western health professions is required to develop ef-
fective safety measures for COTC users.
The trend towards greater alternative medicine use
worldwide necessitates not only stringent labeling regula-
tions and better consumer risk communication, but also
improved surveillance of adverse events. The much higher
rates of adverse events uncovered by this population-
based study mirrors findings from other countries which
found self-reported adverse events exceed those noted by
doctors [57-59]. These findings indicate that adverse event
reporting in an outpatient setting (e.g. web-based report-
ing or adverse event hotlines) should be explored. Im-
proved surveillance of complementary medicines should
be prioritized by governments in order to provide more
comprehensive safety information for health professionals
and consumers.
The main limitation of this study is the lack of clinical
validation of self-reported adverse events some of which
may have been unrelated to COTC use. Alternatively, it
is also possible that some COTC-related adverse drug
reactions may have not been recognized as such by
users. Even among the valid cases of COTC adverse
events that were captured by the study, it was not pos-
sible to determine whether poor drug quality, product
misuse, or drug interaction was the underlying cause of
the adverse event. Moreover, the direction of the positive
association between adverse events and greater informa-
tion seeking behaviors (e.g. reading labels) is unclear.
However, recall biases are likely to be moderate due to
short time frame of the recall period (past year). Lastly,
the reliability of the summative scales (Cronbach’s α ran-
ging from 0.52 to 0.68), indicated that these scales
should only be used for exploratory purposes.
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Despite the limitations noted above, our study can inform
drug policy for other countries that are implementing
complementary medicine regulation. Although the US and
European Union have enacted food and drug regulations
for complementary and alternative medicine products that
will reduce adverse events from poor drug quality, the lack
of understanding of the potential harms of COTC self-
medication and the inaccessibility of reliable information
still pose major obstacles to drug safety.
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